NIH: National Institute of Allergy and Infectious Diseases | Leading research to understand, treat, and prevent infectious, immunologic, and allergic diseases

NIH: National Institute of Allergy and Infectious Diseases | Leading research to understand, treat, and prevent infectious, immunologic, and allergic diseases

November 20, 2019 NIAID Funding News

Read this full edition online at http://www.niaid.nih.gov/grants-contracts/funding-news-notices

Feature Articles 

Making a Conscious Effort To Address Unconscious Bias in Peer Review

To raise reviewers’ awareness of unconscious bias (implicit bias) in peer review, NIAID developed materials to help peer reviewers and review panel chairpersons recognize unconscious bias and minimize its influence.

Opportunities and Resources

Study Sustained Release of HIV Antivirals

Apply to research HIV treatment or prevention products for sustained release platforms by leveraging multidisciplinary approaches to create feasible and practical formulations for sustained release delivery.

Consider an NIAID Contract Opportunity To Establish Influenza Research Centers

A new solicitation seeks Centers of Excellence for Influenza Research and Response sites to study the natural history, transmission, and pathogenesis of influenza and provide critical infrastructure for emergency response.

One Competitive Research Program, Three Options To “SCORE”

The Support of Competitive Research (SCORE) program is designed to increase the research competitiveness of faculty at under-resourced institutions having a stated historical mission focusing on serving students from underrepresented groups. 

In The News

Seeking an Explanation for the Funding Gap Between White and Black Researchers

Researchers at NIH set out to identify the underlying causes of the disparity in success rates between white and black researchers and identified topic selection as a significant contributor.

Small Businesses: Still Time To Apply for Pluripotent Stem Cell Development

Small businesses can apply for Phase II support to develop human induced pluripotent stem cells —mature cells that have been reprogrammed to an embryonic stem cell-like state and are able to differentiate into any cell type in the body.

Review Clarifications to Parent K99/R00, Malaria U01 FOAs

You should always check for updates, clarifications, or changes to a given funding opportunity announcement (FOA) before applying.

Advice Corner

How To Report Misconduct Allegations

Your method for reporting concerns of potential misconduct—plagiarism, misuse of NIH funds, harassment, human subjects at risk, or other similar issues—depends on the type of allegation.

Reader Questions

• “What is an R25? Who is meant to apply for it?”
• “How do I apply to be an intramural scientist at NIAID?”

New Funding Opportunities

• PAR-20-054, Transgender People: Immunity, Prevention, and Treatment of HIV and STIs (R21, Clinical Trial Not Allowed)
• NOT-AI-20-005, Notice of Special Interest: Advancing Research for Tickborne Diseases (TBDs)
• NOT-HL-19-724, Notice of Special Interest: Availability of Administrative and Revision Supplements to Expand Vaping Research and Understand EVALI

Find other announcements at NIAID Opportunities & Announcements.

Send suggestions or comments to deaweb@niaid.nih.gov.